-
1by Nada Abla, Jennifer Keiser, Mireille Vargas, Natalie Reimers, Helmut Haas, Thomas Spangenberg“... in the (R)-enantiomer. Hitherto neither the molecular target nor the pharmacokinetic-pharmacodynamic...”
Published in PLOS Neglected Tropical Diseases (2017)
Get access
Get access
Article in Journal/Newspaper -
2by Andrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, Iñigo Angulo-Barturen, Santiago Ferrer-Bazaga, Simon L Croft, Karin Seifert“... leishmaniasis (VL). Preclinical studies on pharmacokinetics and pharmacodynamics of anti-infective agents...”
Published in PLOS Neglected Tropical Diseases (2021)
Get access
Get access
Article in Journal/Newspaper -
3by Chunhui Hu, Meng Qin, Fabin Zhang, Ruixue Gao, Xuehui Gan, Tao Du“... not affect the efficacy of anti-echinococcosis. In the pharmacodynamics study, ......”
Published in PLOS Neglected Tropical Diseases (2023)
Get access
Get access
Article in Journal/Newspaper -
4by Thomas P C Dorlo, Pieter P A M van Thiel, Gerard J Schoone, Ymkje Stienstra, Michèle van Vugt, Jos H Beijnen, Peter J de Vries“... of quantifying parasite loads in skin lesions as a pharmacodynamic measure and quantitative descriptor of drug...”
Published in PLoS Neglected Tropical Diseases (2011)
Get access
Get access
Article in Journal/Newspaper -
5by Nicole Scherr, Gerd Pluschke, Charles J Thompson, Santiago Ramón-García“...). Time-kill kinetic assays showed bactericidal activity of selamectin and in vitro pharmacodynamic...”
Published in PLOS Neglected Tropical Diseases (2015)
Get access
Get access
Article in Journal/Newspaper -
6by Anna F Fesser, Olivier Braissant, Francisco Olmo, John M Kelly, Pascal Mäser, Marcel Kaiser“... and exposure time. This revealed specific pharmacodynamic profiles of the benchmark drugs benznidazole...”
Published in PLOS Neglected Tropical Diseases (2020)
Get access
Get access
Article in Journal/Newspaper -
7by Ole Lagatie, Emmanuel Njumbe Ediage, Dirk Van Roosbroeck, Stijn Van Asten, Ann Verheyen, Linda Batsa Debrah, Alex Debrah, Maurice R Odiere, Ruben T'Kindt, Emmie Dumont, Koen Sandra, Lieve Dillen, Tom Verhaeghe, Rob Vreeken, Filip Cuyckens, Lieven J Stuyver“.... In addition, to enable pharmacodynamic studies with novel macrofilaricide drug candidates, surrogate endpoints...”
Published in PLOS Neglected Tropical Diseases (2021)
Get access
Get access
Article in Journal/Newspaper -
8by Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P C Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E Kip, Gerard J Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa“... (miltefosine) and pharmacodynamic assessments. RESULTS:In sequential analyses with 49-51 patients per arm...”
Published in PLOS Neglected Tropical Diseases (2016)
Get access
Get access
Article in Journal/Newspaper -
9by Scott McPherson, Anthony W Solomon, Fikre Seife, Hiwot Solomon, Teshome Gebre, David C W Mabey, Michael Marks“... analyzed pharmacokinetic and pharmacodynamic interactions. No study found evidence of clinically...”
Published in PLOS Neglected Tropical Diseases (2023)
Get access
Get access
Article in Journal/Newspaper -
10by Isabel Meister, Jana Kovac, Urs Duthaler, Peter Odermatt, Jörg Huwyler, Fiona Vanobberghen, Somphou Sayasone, Jennifer Keiser“...% for R- and S-PZQ, and between 108-122% for R-trans-4-OH. CONCLUSIONS/SIGNIFICANCE:Pharmacodynamic (PD...”
Published in PLOS Neglected Tropical Diseases (2016)
Get access
Get access
Article in Journal/Newspaper